Fuji Keizai Releases Report on Japanese Immunoassay Market.Tokyo, Japan, Jan 19, 2006 - (JCN) - Japanese market researcher Fuji Keizai has published a report on the immunoassay immunoassay /im·mu·no·as·say/ (-as´a) quantitative determination of antigenic substances (e.g., hormones, drugs, vitamins) by serological means, as by immunofluorescent techniques, radioimmunoassay, etc. im·mu·no·as·say ( market in Japan. The report estimates that the market for diagnostic products reached about 327.5 billion yen ($2.85 bil) in 2005, of which the immunoassay sector accounted for a little under 50%, reaching 154 billion yen ($1.33 bil). In particular, the influenza antigen rapid test kit sector demonstrated significant growth. In line with the flu epidemic in 2004, it is expected to have reached 15.5 billion yen ($134.7 mil) in 2005, up from 10 billion yen ($87.0 mil) in 2003. In addition, three segments in the immunoassay market showed sound growth. They are chemiluminescent assay, latex assay and immunochromato/gold colloid 1. glutinous or resembling glue. 2. a chemical system composed of a continuous medium (continuous phase) throughout which are distributed small particles, 1 to 1000 nm in size (disperse phase), that do not settle out under the influence of gravity; the particles may be in emulsion or in suspension. The term may be used to denote either the particles or the entire system. assay. Entitled Immunoassay Market 2006, the 292-page report (available only in Japanese) sells for 200,000 yen ($1,740). Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion